• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS NUSSLOCH GMBH ASP6025

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS NUSSLOCH GMBH ASP6025 Back to Search Results
Model Number 14049543267
Device Problems Mechanical Jam (2983); Appropriate Term/Code Not Available (3191)
Patient Problem Tissue Damage (2104)
Event Date 03/01/2019
Event Type  Injury  
Manufacturer Narrative
An investigation of the incident is currently underway and a follow up will be submitted should additional information become available following the investigation.
 
Event Description
On (b)(6)2019, leica biosystems received a complaint that they experienced suboptimal tissue processing on their asp6025.On (b)(6) 2019 the customer informed leica biosystems that 152 cassettes were affected, of which 86 were biopsies, and 86 patients had to be rebiopsied.
 
Manufacturer Narrative
Therefore my modified additional manufacturer narrative: the investigation revealed that this was an isolated issue.An instrument valve was inspected by a leica biosystems product specialist at the contract manufacturing site in shanghai.Based on the evaluation, the valve had a blockage caused by a metal burr which lead to cross contamination of the reagents.The instrument valves in stock at the manufacturing site were also checked for burrs with the result that no further valves were affected.A process to ensure valves are free of foreign particles before assembly has been established at the supplier site.Additionally, an incoming goods inspection process to check the valves for foreign particles has been established at the manufacturing site.History: supplement 1: (correction).Field b4: 29-aug-2019.Field g7: follow-up #: 02.Field h2: correction.Field h6: device code: 3049-527.Field h6: method code: 10.Supplement 2: (correction).Field b4: 30-aug-2019.Field g7: follow-up #: 03.Field h6: device code: 1384 - 2983.Supplement 3: (correction - according the support of the cesub team).Field b4: 10-sep-2019.Field g7: follow-up #: 04.Field h6: device code: 3049-527-2983.Field h10: corrected data.Supplement 4: field b4: 12-sep-2019.Field g7: follow-up #: 01.Field h2: additional information.Field h10: history.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASP6025
Type of Device
ASP6025
Manufacturer (Section D)
LEICA BIOSYSTEMS NUSSLOCH GMBH
heidelbergerstr. 17-19
nussloch, 69226
GM  69226
MDR Report Key8477025
MDR Text Key140732691
Report Number8010478-2019-00004
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number14049543267
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-